📽️Celadon Pharmaceuticals feature on BBC Morning Live

Celadon welcomed Dr Amos Ogunkoya into our West Midlands facility to meet CEO James Short to find out about our research into how it could help treat chronic pain.
⁩
#CEL #Medical #Cannabis #NHS #ChronicPain

'I’ve sold my house to pay for my daughter’s medical cannabis'

itv.com/news/2024-04-2…

#CEL #Medical #Cannabis #NHS #Medicine

Celadon's recent contract with a leading European medicinal cannabis company has the potential to generate revenue to Celadon of up to £26 million of product (£8.7 million annually) over the three year term, with the first delivery anticipated in H2 2024.

#CEL #Medical #Cannabis

Our facility is UK’s leading cannabis cultivation and drug development facility has had substantial investment and has involved four years of close cooperation with UK regulators and the MHRA to build to EU-GMP standards and the highest level of security.

#CEL #Medical #Cannabis

Celadon has a 100,000 sq ft licenced facility based in the West Midlands in the UK. It is an EU-GMP facility with indoor hydroponic cultivation of high-THC cannabis flower, API extraction and an R&D lab for its drug development programme.

#CEL #Medical #Cannabis #ChronicPain

Celadon Pharmaceuticals Plc is proud to have been awarded the Made in Britain - official certification. Made in Britain

This achievement reinforces our dedication to contributing positively to the UK economy and healthcare sector.

#CEL #Medical #Cannabis #MadeInBritain

Currently there are thought to be around 35,000 patients with a legal prescription for cannabis in the UK, but estimates have suggested that up to 1.8 million people could be using cannabis accessed illegally to ‘self-medicate’.

cannabishealthnews.co.uk/2024/04/09/cal…

#CEL #Medical #Cannabis

Cannabis grower Curaleaf weighs Europe listing after German legalisation

Sector’s biggest company says it is talking to exchanges in London and Frankfurt

ft.com/content/ecccab…

#CEL #Medical #Cannabis #CANPAIN #Cannabis Medicine #ChronicPain #NHS

The 9th Edition of the longest-standing annual report on Europe's legal cannabis market is now available for pre-order 📗

The report offers the most up-to-date insights and analysis on the evolution of key markets, including: 🇩🇪 🇬🇧 🇨🇭 🇳🇱 🇨🇿

More 👉🏼 eu1.hubs.ly/H08qK9l0

Medical cannabis could soon get the green light in France after unprecedented trial

Preparations to make prescribed cannabis-based medicines more readily available, including in pharmacies, are now under way for 2025.

france24.com/en/europe/2024…

#CEL #Medical #Cannabis #France

Medical Marijuana Patients Report Lasting Quality Of Life Benefits

“It is clear that medical marijuana, when administered safely, can improve an individual’s quality of life,”

forbes.com/sites/ajherrin…

#CEL #MedicalCannabis #Cannabis

Chronic pain is getting in the way of day-to-day life, for eight in 10 sufferers

Poll of 2,000 adults, who experience regular pain, found that as many as 80% say it is getting in the way of their daily lives.

mirror.co.uk/lifestyle/heal…

#CEL #Medical #Cannabis

UK illegal cannabis market estimated at £2.6bn as pain relief demand soars

Globally, the market for medical cannabis is currently valued at $13 billion, with projections suggesting it could reach over $57 billion by 2028.

proactiveinvestors.co.uk/companies/news…

#CEL #Medical #Cannabis

Cannabis-based medicines could be ‘cost-effective’ for treatment of chronic pain

Early economic analysis suggests that at the right price point, cannabis-based medicines could offer a cost-effective alternative for chronic pain.

cannabishealthnews.co.uk/2024/03/12/can…

#CEL #Medical #Cannabis

Our Chair Hannah Deacon was on This Morning discussing the life changing benefits of prescription cannabis for her son Alfie. However, raising the topic once again that many families, remain unable to access similar treatments that have helped Alfie. #savetheunicorn

Pain is reduced by almost half with cannabis-based medicines – report finds

Celadon Pharmaceuticals unveiled promising findings from an early economic analysis of its chronic pain clinical trial, dubbed CANPAIN.

outsourcing-pharma.com/Article/2024/0…

#CEL #Medical #Cannabis

A 5 News investigation reveals that thousands of people, struggling with long-term pain, have been taking addictive opioid medicines for years, when experts say they're only really effective for a few months.

LiveWellWithPain | British Pain Society | FPM | Catherine Jones

Clinical trial will involve up to 5,000 patients and see GP's permitted to prescribe cannabis-based medicines. Once completed NHS will have a proven and cost-effective alternative for managing chronic pain, which we are confident will break down barriers to prescriptions in UK.

As we gear up for full trial, these findings not only reinforce the safety and efficacy of our cannabis-based medicines but also highlight our commitment to addressing the unmet needs of millions of patients.

#CEL #Medical #Cannabis #CANPAIN #Cannabis Medicine #ChronicPain #NHS

Patients on the feasibility study recorded an almost 50% (49.6%) reduction in pain scores in the first month of using cannabis-based medicines, with this reduction in pain being sustained throughout the three-month study.

#CEL #Medical #Cannabis